NUPLAZID

Acadia Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: Jun 18, 2026
Approval ID: 1e6bea44-57d6-4bac-9328-46e1ee59f83b
Products: 2 registered
Version: 23

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NUPLAZID safely and effectively. See full prescribing information for NUPLAZID. NUPLAZID (pimavanserin) capsules, for oral use NUPLAZID (pimavanserin) tablets, for oral use Initial U.S. Approval: 2016

Quick Stats

Total Products2

Labelers2

Label Sections26

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.